Key deals this week: Amcor, ONEOK, Grifols, N-able and more
Packaging solutions company Amcor (AMCR) has agreed to acquire peer Berry Global Group (BERY) in an $8.4B all-stock ...
The Corner3d
Grifols believes Brookfield’s non-binding offer greatly undervalues fundamental prospects and long-term potential
Santander Credit Research | Grifols (B+ s, B+ s) yesterday informed the CNMV that it has received a non-binding offer from ...
The Corner3d
Brookfield closes refinancing of Grifols debt for €11,000 million with Deutsche Bank and Banco Santander
Link Securities | The Canadian private equity fund Brookfield has taken a definitive step to take control of GRIFOLS (GRF) ...
FiercePharma4d
Plasma specialist Grifols shrugs off private equity firm Brookfield's potential €6.5B takeover offer
With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...
Grifols says potential Brookfield offer ‘significantly undervalues’ shares
Grifols (GRFS) informs that its board has held an extraordinary meeting this afternoon “without the intervention of the conflicted board ...
Grifols Board Issues Unfavorable Opinion on Brookfield Offer
Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...
Grifols slips as board rebuffs Brookfield’s $6.8B offer (update)
ADRs fell ~6% on Tuesday after its board of directors declined to recommend Brookfield Asset Management's (NYSE:BAM) ...
Grifols Signals It Would Reject $6.8 Billion Brookfield Bid
Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...
Spain Court Opens Probe Into 'Misleading' US Hedge Fund
A Spanish court on Tuesday said it was investigating the US hedge fund Gotham City for allegedly publishing "misleading" information about Spanish pharmaceutical firm Grifols, causing its shares to ...
Grifols doses first patient in Phase 1 trial of GIGA-2339
GigaGen announced that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of the first ...